Acute Myeloid Leukemia

Research from H. Nakasone and co-researchers in the area of acute myeloid leukemia described

Published in Medical Devices and Surgical Technology Week, January 4th, 2009

"Although core-binding factor acute myeloid leukemia (CBF-AML) is generally considered to be a low-risk form of AML, the survival rate is still 50% to 60%. To evaluate the effectiveness of autologous stem cell transplantation (ASCT) with a PCR-negative graft we analyzed a series of consecutive CBF-AML patients," investigators in Tokyo, Japan report.

"Between 1997 and 2006, 18 patients aged <60 years were referred under a diagnosis of CBF-AML. Peripheral blood stem cells (PBSC) were collected after a second or further course of postremission therapy. When >2.0 x 10(6)/kg CD34-positive cells with minimal residual disease (MRD) undetectable by nested polymerase chain...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Medical Devices and Surgical Technology Week

Source: Medical Devices and Surgical Technology Week (2009-01-04)

More Articles from Medical Devices and Surgical Technology Week

American Society for Gastrointestinal Endoscopy
Narrow-band imaging comparable to white light colonoscopy in differentiating colorectal polyps
Pharmacology
NicOx' Naproxcinod Shows Differentiated 24-Hour Blood Pressure Profile After 13 Weeks Treatment
Prostate Cancer
Prostate Cancer Discovered in 40 Percent of Men Who Test Negative for the Disease
Acid Reflux Disease
New acid reflux disease study findings have been reported by scientists at University of Cologne
Adenocarcinoma
Studies from J.H. Rubenstein and co-researchers update current data on adenocarcinoma
Adenoid Cystic Cancer
Research from University of Iowa yields new findings on adenoid cystic cancer
More from this issue of Medical Devices and Surgical Technology Week

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry